Biological Products, (No Diagnostic Substances) · DE · CIK 1815442
Kymera Therapeutics develops oral medicines using targeted protein degradation to eliminate disease-causing proteins
Comparable business profile · signals at a glance
Coverage (30d): 2 reputable articles · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 25, 2026: 6 sold $26.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 24,727 | $80.26 | $2.0M |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 52,975 | $77.21 | $4.1M |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 22,756 | $76.73 | $1.7M |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 8,214 | $78.40 | $644K |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 6,105 | $79.87 | $488K |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 1,200 | $80.05 | $96K |
| Mar 20, 2026 | Esposito PamelaDirector | Sell | 1,200 | $79.94 | $96K |
| Mar 20, 2026 | Esposito PamelaDirector | Sell | 700 | $77.71 | $54K |
| Mar 20, 2026 | Esposito PamelaDirector | Sell | 600 | $79.24 | $48K |
| Mar 11, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 12,882 | $83.10 | $1.1M |
| Mar 11, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 11,111 | $83.72 | $930K |
| Mar 11, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 1,765 | $82.13 | $145K |
| Mar 4, 2026 | Gollob JaredChief Medical Officer | Sell | 2,519 | $85.04 | $214K |
| Mar 4, 2026 | Jacobs Bruce N.Chief Financial Officer | Sell | 2,519 | $85.04 | $214K |
| Mar 4, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 2,017 | $85.04 | $172K |
| Mar 4, 2026 | Gollob JaredChief Medical Officer | Sell | 1,437 | $85.78 | $123K |
| Mar 4, 2026 | Jacobs Bruce N.Chief Financial Officer | Sell | 1,437 | $85.78 | $123K |
| Mar 4, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 1,150 | $85.78 | $99K |
| Mar 4, 2026 | Gollob JaredChief Medical Officer | Sell | 492 | $84.00 | $41K |
| Mar 4, 2026 | Jacobs Bruce N.Chief Financial Officer | Sell | 492 | $84.00 | $41K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.